Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
J Thromb Thrombolysis. 2017 May;43(4):484-489. doi: 10.1007/s11239-017-1479-z.
J Thromb Thrombolysis. 2017.
PMID: 28210989
Free PMC article.
A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points.
O'Donnell A, Padhani A, Hayes C, Kakkar AJ, Leach M, Trigo JM, Scurr M, Raynaud F, Phillips S, Aherne W, Hardcastle A, Workman P, Hannah A, Judson I.
O'Donnell A, et al. Among authors: kakkar aj.
Br J Cancer. 2005 Oct 17;93(8):876-83. doi: 10.1038/sj.bjc.6602797.
Br J Cancer. 2005.
PMID: 16222321
Free PMC article.
Clinical Trial.
Item in Clipboard
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.
Jones PH, Christodoulos K, Dobbs N, Thavasu P, Balkwill F, Blann AD, Caine GJ, Kumar S, Kakkar AJ, Gompertz N, Talbot DC, Ganesan TS, Harris AL.
Jones PH, et al. Among authors: kakkar aj.
Br J Cancer. 2004 Jul 5;91(1):30-6. doi: 10.1038/sj.bjc.6601897.
Br J Cancer. 2004.
PMID: 15162145
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite